Please enable JS

NJ Spotlight – Op/Ed – Why Would Drug-Store Lobby Back Bill That Conceals ‘Biosimilar’ Switch?

7/ 10

ARTICLE DETAILS

AUTHOR: 50SN Staff

DATE: Jul 10, 2015

TAGS:

SHARE ON: Twitter - Facebook - LinkedIn

MEDIA CONTACT
Name :
Phone:
Email:

NJ Spotlight – Op/Ed – Why Would Drug-Store Lobby Back Bill That Conceals ‘Biosimilar’ Switch?

In today’s expensive and increasingly complex healthcare environment, the holy grail of positive health outcomes hinges on several variables. Most would believe that these variables go something like this: access to quality physicians and medical experts, early diagnoses, aggressive treatment, patient compliance, and active monitoring. However, if you ask patients with severe chronic diseases what they believe is the one factor most important in achieving a positive outcome for their condition or disease, the vast majority have a similar answer: their relationship with their physician.